• Cy3 Goat Anti-Human IgG (H+L) Antibody Workflow

  2026-09-17

  Build sensitive human IgG readouts across immunofluorescence, tissue imaging, flow cytometry, and ELISA with a Cy3 conjugated secondary antibody. This practical guide connects assay design, quantified starting conditions, controls, and troubleshooting to antibody-engineering research without overstating what the reagent can prove.

• Pterostilbene, Mitochondrial Quality, and Dermal Senescence

  2026-09-17

  Zhou et al. show that pterostilbene reduces senescence in human dermal fibroblasts exposed to UVB-associated oxidative stress or replicative aging. The study links this effect to improved mitochondrial morphology, membrane potential, respiration, and mitophagy, with supporting evidence from a UVB-exposed mouse model.

• Iron Stress Reprograms Enterocyte Metabolism

  2026-09-16

  Navazesh and Ji show that iron deficiency and iron excess produce distinct transcriptional and metabolic states in IPEC-J2 enterocytes. Their combined gene-expression, inflammatory-challenge, proliferation, and untargeted-metabolomics design clarifies how iron availability influences intestinal epithelial resilience and recovery after iron repletion.

• Dasatinib (BMS-354825) Experimental Workflows

  2026-09-16

  Build reproducible kinase-signaling experiments with Dasatinib, from Src and Bcr-Abl pathway interrogation to phospho-FAK assays and translational cancer models. This guide connects validated product-use conditions with the SNAI1–PIK3R2/p-EphA2 findings in thymic tumors while clearly separating evidence from testable hypotheses.

• Azilsartan Medoxomil Monopotassium in Translation

  2026-09-15

  Azilsartan medoxomil monopotassium, also known as TAK 491 monopotassium, offers translational researchers a tightly defined way to interrogate AT1 receptor biology across molecular, preclinical, and clinical research. This article connects receptor kinetics, experimental design, meta-analytic evidence, and strategic study planning for hypertension and cardiovascular disease research.

• Nintedanib: Genotype-Aware Research Design

  2026-09-15

  Nintedanib (BIBF 1120) is a multi-target angiokinase inhibitor with value beyond conventional antiangiogenic screening. This article presents an ATRX-informed framework for connecting receptor coverage, assay design, and translational interpretation across cancer and fibrosis research.

• VIK–Auxin Signaling in Arabidopsis Lateral Roots

  2026-09-14

  The reference study identifies the auxin-activated kinase VIK as a phosphorylation-based regulator of lateral root development in Arabidopsis. Its central contribution is a dual mechanism in which VIK stabilizes the positive regulator LBD18 while promoting degradation of the repressor ERF13, linking auxin signaling to coordinated control of protein stability.

• Rapid Microwave Heating Preserves Lactoferrin

  2026-09-14

  The reference study shows that heating rate, rather than a distinct microwave dielectric effect, is the dominant factor preserving lactoferrin structure and bioactivity during treatment at 70–90 °C. By comparing microwave, conventional thermal, and microwave-simulated conventional heating, the authors connect rapid passage through the denaturation range with reduced aggregation and retention of antioxidant, anti-inflammatory, and anti-apoptotic functions.

• RBM3, MEF2C, and BBB Integrity in Alzheimer’s Disease

  2026-09-13

  The reference study identifies an RBM3–MEF2C regulatory axis that links post-transcriptional mRNA stabilization to tight-junction gene expression and blood–brain barrier permeability in an Alzheimer’s disease microenvironment. Its combination of RNA-binding, transcriptional, and barrier-function assays provides a mechanistic framework for studying how amyloid-β-associated endothelial stress weakens the BBB.

• Niclosamide: STAT3 Mechanism and Research Workflow

  2026-09-12

  Niclosamide is a small-molecule STAT3 pathway inhibitor with a reported IC50 of 0.7 μM. It inhibits STAT3 Tyr-705 phosphorylation, supports mechanistic cancer research, and has documented activity in Du145 cells and an HL-60 xenograft model.

• Caveolin-1 Restores Cholesterol Homeostasis in MASLD

  2026-09-11

  The reference study identifies caveolin-1 as a regulator of hepatic cholesterol homeostasis whose loss intensifies endoplasmic reticulum stress and pyroptosis during MASLD. By combining CAV1-deficient mice, liver transcriptomics, human samples, and in vitro validation, the authors connect CAV1 with the FXR/NR1H4–ABCG5/ABCG8 pathway and provide a mechanistic framework for studying cholesterol-driven liver injury.

• Ceruletide in Pancreatic Fibrosis Research

  2026-09-11

  Ceruletide, also known as Caerulein, provides a reproducible CCK-receptor stimulus for pancreatic injury, exocrine-function, and gastrointestinal motility workflows. This guide connects model selection and sample handling with the ORM2–ZG16 autophagy findings, helping researchers distinguish physiological disease modeling from pathway-specific validation.

• Chronic Cabozantinib Rewires RCC Phosphosignaling

  2026-09-10

  This study uses quantitative phosphoproteomics to show that acute and chronic Cabozantinib exposure produce distinct phosphorylation states in renal cell carcinoma cells. Chronic treatment maintained MET activation-loop suppression but selectively enriched adhesion-, stress-, and MAPK/AP-1-associated signaling, with modest, pattern-specific changes in migration and invasion.

• LP.P101, AMPK, and Alcoholic Liver Steatosis

  2026-09-10

  A 2025 mouse study combined probiotic intervention, pharmacological AMPK inhibition, gut microbiota profiling, and serum metabolomics to investigate how Lactiplantibacillus plantarum P101 limits alcohol-induced hepatic lipid accumulation. Its findings support AMPK activation as a necessary component of the probiotic response while identifying microbiota and metabolite changes that may connect the gut to liver lipid metabolism.

• Cy5 TSA Fluorescence System Kit: Assay Design

  2026-09-09

  The Cy5 TSA Fluorescence System Kit enables high-sensitivity spatial assays for endothelial–cardiomyocyte injury biology. This article connects tyramide chemistry with mechanistic decisions for detecting low-abundance targets in immunohistochemistry, immunocytochemistry, and in situ hybridization.

8453 records 1/564 page Next 12345 下5页 Last page